BANDUNG: Indonesia will be given priority access to the technical know-how on producing the Chinese-made COVID-19 vaccine once the candidate obtains regulatory approval, an official said on Wednesday ., which is one of the few in the world to enter phase 3 clinical trials.“Of course we’ll get priority, it is their commitment,” said Bio Farma’s head of clinical trials Rini Mulia Sari.
They will test the vaccine candidate, known as CoronaVac, on 1,620 volunteers for six months. Sinovac will also conduct trials in several other countries such as Brazil and Bangladesh.Advertisement“There will also be a transfer of technology. So, the ones that will be marketed will be those manufactured at Bio Farma, meaning it will carry Bio Farma's brand,” said Ms Sari during a media briefing at Bio Farma's premises in Bandung.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sinovac launches late-stage trial for potential Covid-19 vaccine in IndonesiaJAKARTA/BEIJING (REUTERS) - China's Sinovac Biotech launched on Tuesday(Aug 11) a late-stage human trial involving as many as 1,620 patients in Indonesia for a Covid-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Sinovac launches late-stage trial for potential COVID-19 vaccine in IndonesiaJAKARTA: China's Sinovac Biotech launched on Tuesday (Aug 11) a late-stage human trial involving as many as 1,620 patients in Indonesia for a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Potential COVID-19 vaccine jointly developed by Duke-NUS and Arcturus begins human trialsSINGAPORE: The first participants of an early-stage COVID-19 vaccine trial have been given the potential vaccine, said Arcturus Therapeutics ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
China's Sinopharm starts Phase III trial of COVID-19 vaccine in BahrainChinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Bahrain, after launching similar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Philippines' Duterte has 'huge trust' in Russia COVID-19 vaccine, volunteers for trialPhilippine President Rodrigo Duterte has lauded Russia's efforts to develop a coronavirus vaccine and is willing to participate in trials, as he ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Alarm among global health experts after Russia's COVID-19 vaccine set to be approved without full trial dataLONDON: An announcement by Russia on Tuesday (Aug 11) that it will approve a COVID-19 vaccine after less than two months of human testing prompted ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »